Page last updated: 2024-08-23

brofaromine and Claustrophobia

brofaromine has been researched along with Claustrophobia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (80.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanco, C; Blanco-Jerez, CR; Liebowitz, MR; Marshall, RD; Sánchez-Lacay, A; Schmidt, A; Schneier, FR1
den Boer, JA; Slaap, BR; van Vliet, IM; Westenberg, HG2
Gimbrett, R; Priest, RG; Roberts, M; Steinert, J1
Fallon, BA; Feerick, J; Liebowitz, MR; Marshall, RD; Schneier, FR1
Bakish, D1
Fahlén, T1
Borg, K; Fahlén, T; Humble, M; Nilsson, HL; Pauli, U1
Schneier, FR1
den Boer, JA; van Vliet, IM; Westenberg, HG1

Reviews

3 review(s) available for brofaromine and Claustrophobia

ArticleYear
Pharmacological treatment of social anxiety disorder: a meta-analysis.
    Depression and anxiety, 2003, Volume: 18, Issue:1

    Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Anxiety Disorders; Calcium Channel Blockers; Clonazepam; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2003
Medication therapy for social phobia.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Benzamides; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

1994
Treatment of social phobia with antidepressants.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 1

    Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Drug Approval; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Phenelzine; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States

2001

Trials

6 trial(s) available for brofaromine and Claustrophobia

ArticleYear
Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Journal of affective disorders, 1995, Jan-11, Volume: 33, Issue:1

    Topics: Adult; Agoraphobia; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Panic; Panic Disorder; Personality Inventory; Phobic Disorders; Piperidines; Prognosis; Treatment Outcome

1995
The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:1

    Topics: Adult; Agoraphobia; Humans; Male; Monoamine Oxidase Inhibitors; Panic Disorder; Phobic Disorders; Piperidines

1994
Personality traits in social phobia, II: Changes during drug treatment.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:12

    Topics: Adult; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Mood Disorders; Personality Disorders; Phobic Disorders; Piperidines; Placebos; Self Concept; Treatment Outcome

1995
Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.
    Acta psychiatrica Scandinavica, 1995, Volume: 92, Issue:5

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

1995
Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response.
    Journal of affective disorders, 1996, Jun-20, Volume: 39, Issue:1

    Topics: Adult; Arousal; Blood Pressure; Double-Blind Method; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Phobic Disorders; Piperidines; Prognosis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

1996
Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1992, Volume: 2, Issue:1

    Topics: Adult; Blood Pressure; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Melatonin; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Phobic Disorders; Piperidines; Psychiatric Status Rating Scales

1992

Other Studies

1 other study(ies) available for brofaromine and Claustrophobia

ArticleYear
Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 386

    Topics: Alzheimer Disease; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Benzamides; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Panic Disorder; Phobic Disorders; Piperidines

1995